FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to biotechnology, particularly to producing PEGylated granulocyte colony-stimulating factor (G-CSF), and is applicable in medicine. What is produced is a conjugate of G-CSF and monomethoxypolyethylene glycol attached to N-terminal methionine of the G-CSF of general formula: 
 wherein n is integers within 681 to 1 000; m represents an integer ≥4; NαH-G-CSF represents the granulocyte colony-stimulating factor.
EFFECT: produced conjugate exhibits human G-CSF activity and prolonged biological action that makes it possible to use it in pharmaceutical compositions, and as a drug preparation for preventing and treating neutropenias.
17 cl, 10 dwg, 5 tbl, 21 ex
| Title | Year | Author | Number | 
|---|---|---|---|
| NOVEL FUNCTIONALLY ACTIVE, HIGHLY PURE, STABLE CONJUGATE OF INTERFERON α WITH POLYETHYLENE GLYCOL, REPRESENTED BY ONE PEG- NH-IFN POSITIONAL ISOMER, WITH IMPROVED IMMUNOGENICITY, WITH PROLONGED BIOLOGICAL ACTION, SUITABLE FOR MEDICAL APPLICATION, AND IMMUNOLOGICAL AGENT BASED THEREON | 2010 | 
									
  | 
                RU2447083C1 | 
| PEG-MODIFIED HUMAN INTERFERON β-1a MOLECULE WITH ANTIVIRAL, IMMUNOMODULATORY AND ANTIPROLIFERATIVE ACTIVITY, WITH IMPROVED STABILITY, REDUCED IMMUNOGENICITY, IMPROVED PHARMACOKINETIC AND PHARMACODYNAMIC PARAMETERS, SUITABLE FOR MEDICAL USE, AND IMMUNOBIOLOGICAL FORMULATION BASED THEREON | 2013 | 
									
  | 
                RU2576372C2 | 
| CONJUGATE OF POLYETHYLENE GLYCOL- G-CSF | 2006 | 
									
  | 
                RU2423133C2 | 
| TARGETED COLONY-STIMULATING AGENT | 2020 | 
									
  | 
                RU2749509C1 | 
| EXTENDED FACTOR OF HUMAN ERYTHROPOIESIS AND A THERAPEUTIC AGENT BASED THEREON | 2015 | 
									
  | 
                RU2664588C2 | 
| PEG DENDRIMER WITH FOUR BRANCHES FOR CONJUGATION WITH PROTEINS AND PEPTIDES | 2006 | 
									
  | 
                RU2409389C2 | 
| METHOD OF PREPARING HUMAN RECOMBINANT GRANULOCYTIC COLONY-STIMULATING FACTOR | 2001 | 
									
  | 
                RU2201962C2 | 
| METHOD FOR PREPARING, ISOLATING, PURIFYING AND STABILIZING HUMAN RECOMBINANT GRANULOCYTIC COLONY-STIMULATING FACTOR USEFUL FOR MEDICINAL USING AND IMMUNOBIOLOGICAL AGENT BASED ON THEREOF | 2004 | 
									
  | 
                RU2278870C2 | 
| RECOMBINANT PLASMID DNA PES3-7 ENCODING PEPTIDE WITH SEQUENCE OF HUMAN GRANULOCYTE COLONY-STIMULATING FACTOR (G-CSF) AND STRAIN ESCHERICHIA COLI BL21(DE3)/PES3-7 AS PRODUCER OF HUMAN RECOMBINANT G-CSF | 2003 | 
									
  | 
                RU2260049C2 | 
| RECOMBINANT PLASMID DNA pFGM17 ENCODING POLYPEPTIDE OF HUMAN GRANULOCYTIC-MACROPHAGAL COLONY-STIMULATING FACTOR AND STRAIN OF BACTERIUM Escherichia coli BL21(DE3)/pFGM17 AS PRODUCER OF POLYPEPTIDE OF HUMAN GRANULOCYTIC-MACROPHAGAL COLONY-STIMULATING FACTOR | 2004 | 
									
  | 
                RU2271392C1 | 
Authors
Dates
2012-03-27—Published
2010-08-13—Filed